Metastatic Lung Cancer Treatment Gets FDA Nod Of Approval On Monday, FDA has greenlighted Iressa (gefitinib) as treatment for patients with metastatic NSCLC characterized by certain EGFR gene mutations. by Rhodi Lee
Xi Jinping Warns Against Chip Restrictions During Talks with Dutch PM Rutte: 'No Force Can Stop China's Progress'
Researchers Achieve Record Data Transmission Speed, 4.5 Million Times Faster Than Average Home Broadband